Clin Mol Hepatol > Volume 29(4); 2023 > Article |
|
Predictors | Number of events | Univariable HR (95% CI) | P-value | Multivariable HR Model 1a (95% CI) | P-value | Multivariable HR Model 2a (95% CI) | P-value | |
---|---|---|---|---|---|---|---|---|
NAFLD-i | ||||||||
White | 504 | 1 | 1 | 1 | ||||
Black | 13 | 0.60 (0.34–1.04) | 0.07 | 0.58 (0.34–1.01) | 0.05 | 0.54 (0.31–0.94) | 0.03 | |
Hispanic | 232 | 0.82 (0.70–0.96) | 0.01 | 0.99 (0.84–1.16) | 0.89 | 1.02 (0.87–1.20) | 0.80 | |
Asian | 245 | 0.72 (0.62–0.84) | <0.0001 | 0.81 (0.70–0.95) | 0.008 | 0.84 (0.71–0.99) | 0.03 | |
Cirrhosis | ||||||||
White | 412 | 1 | 1 | 1 | ||||
Black | 11 | 0.63 (0.35–1.15) | 0.13 | 0.61 (0.34–1.11) | 0.11 | 0.56 (0.31–1.02) | 0.06 | |
Hispanic | 202 | 0.89 (0.75–1.05) | 0.17 | 1.06 (0.89–1.26) | 0.51 | 1.10 (0.92–1.32) | 0.29 | |
Asian | 199 | 0.72 (0.61–0.85) | <0.0001 | 0.81 (0.68–0.96) | 0.02 | 0.85 (0.71–1.03) | 0.09 | |
Hepatocellular carcinomab | ||||||||
White | 3 | 1 | 1 | 1 | ||||
Hispanic | 3 | 1.88 (0.38–9.30) | 0.44 | 3.38 (0.65–17.55) | 0.15 | 3.74 (0.71–19.6) | 0.12 | |
Asian | 2 | 1.15 (0.19–6.89) | 0.88 | 1.48 (0.25–8.92) | 0.67 | 1.94 (0.30–12.43) | 0.48 | |
Liver-related mortalityb | ||||||||
White | 10 | 1 | 1 | 1 | ||||
Hispanic | 13 | 2.64 (1.16–6.03) | 0.02 | 3.84 (1.63–9.04) | 0.002 | 3.89 (1.51–10.03) | 0.005 | |
Asian | 4 | 0.65 (0.21–2.09) | 0.47 | 0.78 (0.25–2.51) | 0.68 | 0.88 (0.25–3.07) | 0.84 |
HR, hazard ratios; CI, confidence interval; NAFLD, non-alcoholic fatty liver disease; NAFLD-i, non-alcoholic fatty liver disease with stage 1 fibrosis or higher.
Predictors | Number of events | Univariable HR (95% CI) | P-value | Multivariable HR Model 1a (95% CI) | P-value | Multivariable HR Model 2a (95% CI) | P-value | |
---|---|---|---|---|---|---|---|---|
Overall mortality | ||||||||
White | 137 | 1 | 1 | 1 | ||||
Black | 10 | 2.05 (1.07–3.91) | 0.029 | 2.13 (1.11–4.08) | 0.022 | 1.93 (0.96–3.85) | 0.06 | |
Hispanic | 65 | 0.95 (0.71–1.30) | 0.77 | 1.44 (1.05–1.99) | 0.022 | 1.53 (1.09–2.16) | 0.02 | |
Asian | 49 | 0.57 (0.40–0.80) | 0.002 | 0.70 (0.50–1.00) | 0.053 | 0.81 (0.55–1.20) | 0.29 | |
Non-liver-related mortality | ||||||||
White | 127 | 1 | 1 | 1 | ||||
Black | 10 | 2.22 (1.16–4.25) | 0.015 | 2.35 (1.22–4.51) | 0.010 | 2.05 (1.02–4.12) | 0.04 | |
Hispanic | 52 | 0.81 (0.57–1.13) | 0.227 | 1.23 (0.87–1.75) | 0.22 | 1.33 (0.91–1.93) | 0.14 | |
Asian | 45 | 0.56 (0.39–0.81) | 0.002 | 0.70 (0.48–1.01) | 0.059 | 0.81 (0.53–1.22) | 0.31 |
Mindie H. Nguyen
https://orcid.org/0000-0002-6275-4989
Global incidence and prevalence of nonalcoholic fatty liver disease2023 February;29(Suppl)